Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Parathyroid Glands00:59

The Parathyroid Glands

The two pairs of parathyroid glands embedded within the posterior surface of the thyroid gland are restricted by a dense capsule around them. These glands comprise two distinct cell populations—parathyroid oxyphil and parathyroid principal cells- pivotal in calcium homeostasis.
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by producing...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Do have patients with "Hashimoto disease" to be operated on? A critical reading of The Norvegian Trial Surgery Study, a prospective randomized investigation published in Annals of Internal Medicine (2019)].

La Revue de medecine interne·2020
Same author

Risk-benefit ratio for TSH- suppressive Levothyroxine therapy in differentiated thyroid cancer.

Annales d'endocrinologie·2016
Same author

2013 European thyroid association guidelines for the diagnosis and treatment of thyrotropin-secreting pituitary tumors.

European thyroid journal·2014
Same author

Guidelines of the French society of endocrinology for the management of thyroid nodules.

Annales d'endocrinologie·2011
Same author

[Editorial Klotz thyroid].

Annales d'endocrinologie·2011
Same author

Hypercalcitonemia revealing a somatostatinoma.

Annales d'endocrinologie·2010

Related Experiment Video

Updated: Jun 23, 2026

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy
03:57

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy

Published on: July 14, 2023

[Primary hyperparathyroidism].

J-L Wémeau1

  • 1Clinique Endocrinologique Marc Linquette, CHU de Lille, 6 rue du Professeur Laguesse, 59037 Lille cedex, France. jl-wemeau@chru-lille.fr

Journal De Radiologie
|May 8, 2009
PubMed
Summary

Primary hyperparathyroidism is a common endocrine disorder, often diagnosed in post-menopausal women. Surgery is recommended for those under 50 or experiencing symptoms, particularly with osteoporosis.

Area of Science:

  • Endocrinology
  • Genetics

Background:

  • Primary hyperparathyroidism is a frequent endocrine disorder.
  • It predominantly affects post-menopausal women and is often mildly progressive.

Purpose of the Study:

  • To summarize the epidemiology and management of primary hyperparathyroidism.
  • To highlight indications for surgical intervention.
  • To discuss genetic factors in familial hyperparathyroidism.

Main Methods:

  • Literature review of primary hyperparathyroidism.
  • Analysis of diagnostic criteria and treatment guidelines.
  • Review of genetic mutations associated with familial forms.

Main Results:

  • Most new cases occur in post-menopausal women.

More Related Videos

Establishment of a Simple and Effective Rat Model for Intraoperative Parathyroid Gland Imaging
07:12

Establishment of a Simple and Effective Rat Model for Intraoperative Parathyroid Gland Imaging

Published on: August 17, 2022

Related Experiment Videos

Last Updated: Jun 23, 2026

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy
03:57

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy

Published on: July 14, 2023

Establishment of a Simple and Effective Rat Model for Intraoperative Parathyroid Gland Imaging
07:12

Establishment of a Simple and Effective Rat Model for Intraoperative Parathyroid Gland Imaging

Published on: August 17, 2022

  • Surgery is crucial for patients under 50 and symptomatic individuals, especially those with osteoporosis.
  • Familial hyperparathyroidism involves specific gene mutations (MEN1, MEN2, HRPT 1 and 2) and a calcium sensor, influencing management and prognosis.

    • Conclusions:

    • Timely surgical intervention is key for specific patient groups.
    • Genetic testing is important for familial hyperparathyroidism cases due to varied outcomes.
    • Understanding the underlying causes and patient-specific factors is vital for effective management.